The authors reported that TERT promoter DNA methylation upregulates TERT expression and associates with poor clinical outcomes of papillary thyroid cancer (PTC), thus holding the potential to be a valuable prognostic marker for PTC risk stratification [44]. This evidence concerns the gene TERT and thyroid gland papillary carcinoma.